Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex
Clinical trial NCT06004037 · COMPLETED
Trial details
- NCT number
- NCT06004037
- Sponsor
- LigaChem Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-16
- Primary completion
- 2025-09-15
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.